Nuclear receptor modulation - Role of coregulators in selective estrogen receptor modulator (SERM) actions

被引：40

作者：

Feng, Qin ^{[1
]}

O'Malley, Bert W. ^{[1
]}

机构：

[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA

来源：

STEROIDS | 2014年 / 90卷

关键词：

SERM; Nuclear receptor; Coregulator; HORMONE-REPLACEMENT THERAPY; BREAST-CANCER CELLS; STEROID-RECEPTOR; TAMOXIFEN RESISTANCE; ER-ALPHA; N-COR; HISTONE ACETYLTRANSFERASE; MOLECULAR DETERMINANTS; COREPRESSOR BINDING; SIGNALING PATHWAYS;

D O I：

10.1016/j.steroids.2014.06.008

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Selective estrogen receptor modulators (SERMs) are a class of small-molecule chemical compounds that bind to estrogen receptor (ER) ligand binding domain (LBD) with high affinity and selectively modulate ER transcriptional activity in a cell- and tissue-dependent manner. The prototype of SERMs is tamoxifen, which has agonist activity in bone, but has antagonist activity in breast. Tamoxifen can reduce the risk of breast cancer and, at same time, prevent osteoporosis in postmenopausal women. Tamoxifen is widely prescribed for treatment and prevention of breast cancer. Mechanistically the activity of SERMs is determined by the selective recruitment of coactivators and corepressors in different cell types and tissues. Therefore, understanding the coregulator function is the key to understanding the tissue selective activity of SERMs. (C) 2014 Elsevier Inc. All rights reserved.

引用

页码：39 / 43

页数：5

共 63 条

[1] Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer [J].

Al-Azawi, D. ;

Mc Ilroy, M. ;

Kelly, G. ;

Redmond, A. M. ;

Bane, F. T. ;

Cocchiglia, S. ;

Hill, A. D. K. ;

Young, L. S. .

ONCOGENE, 2008, 27 (21) :3021-3031

[2] AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].

Anzick, SL ;

Kononen, J ;

Walker, RL ;

Azorsa, DO ;

Tanner, MM ;

Guan, XY ;

Sauter, G ;

Kallioniemi, OP ;

Trent, JM ;

Meltzer, PS .

SCIENCE, 1997, 277 (5328) :965-968

[3]

Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0

[4]

Beral Valerie, 2003, Lancet, V362, P419

[5] Molecular basis of agonism and antagonism in the oestrogen receptor [J].

Brzozowski, AM ;

Pike, ACW ;

Dauter, Z ;

Hubbard, RE ;

Bonn, T ;

Engstrom, O ;

Ohman, L ;

Greene, GL ;

Gustafsson, JA ;

Carlquist, M .

NATURE, 1997, 389 (6652) :753-758

[6] Regulation of transcription by a protein methyltransferase [J].

Chen, DG ;

Ma, H ;

Hong, H ;

Koh, SS ;

Huang, SM ;

Schurter, BT ;

Aswad, DW ;

Stallcup, MR .

SCIENCE, 1999, 284 (5423) :2174-2177

[7] Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 [J].

Chen, HW ;

Lin, RJ ;

Schiltz, RL ;

Chakravarti, D ;

Nash, A ;

Nagy, L ;

Privalsky, ML ;

Nakatani, Y ;

Evans, RM .

CELL, 1997, 90 (03) :569-580

[8] A TRANSCRIPTIONAL CO-REPRESSOR THAT INTERACTS WITH NUCLEAR HORMONE RECEPTORS [J].

CHEN, JD ;

EVANS, RM .

NATURE, 1995, 377 (6548) :454-457

[9] Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene [J].

Daverey, Amital ;

Saxena, Ruchi ;

Tewari, Shikha ;

Goel, Sudhir K. ;

Dwivedi, Anila .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 116 (1-2) :93-101

[10] Energy metabolism and fertility-a balance preserved for female health [J].

Della Torre, Sara ;

Benedusi, Valeria ;

Fontana, Roberta ;

Maggi, Adriana .

NATURE REVIEWS ENDOCRINOLOGY, 2014, 10 (01) :13-23

← 1 2 3 4 5 6 7 →